Marex Group’s Bon Natural Life BON Stock Holding History

Marex Group’s Portfolio BON Stock Details BON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,848	Closed	-$6.66K	–	678
2025 Q1	$6.66K	Buy	+2,848	New	+$77.8K	﹤0.01%	674

Other funds holding BON

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Marex Group's BON Position: Q2 2025 in Review

Marex Group sold out of Bon Natural Life (BON) in Q2 2025, closing a stake of 2,848 shares — an estimated $6.66K sold.

Marex Group first reported a position in BON in Q1 2025 and held it in 1 quarter. The position peaked at $6.66K in Q1 2025. 4 funds tracked by Wall St. Rank hold BON as of Q2 2025.

Marex Group reported no remaining Bon Natural Life position as of Q2 2025 after selling out during the quarter.
Marex Group sold 2,848 Bon Natural Life shares in Q2 2025, an estimated $6.66K.
Marex Group first reported a position in Bon Natural Life in Q1 2025 and held it in 1 quarter.
Marex Group's Bon Natural Life position peaked at $6.66K in Q1 2025.
4 funds tracked by Wall St. Rank held Bon Natural Life as of Q2 2025.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.